Synergy between an antibody and CD8(+) cells in eliminating an established tumor Journal Article


Authors: Vasović, L. V.; Dyall, R.; Clynes, R. A.; Ravetch, J. V.; Nikolić-Žugić, J.
Article Title: Synergy between an antibody and CD8(+) cells in eliminating an established tumor
Abstract: We investigated the effector mechanisms operating during the rejection of a transplantable solid lymphoma E.G7 (H-2b) which expresses the gene encoding chicken ovalbumin (OVA). Anti-OVA cytotoxic T lymphocytes (CTL) completely and specifically protected animals from the onset of, but could not eradicate established, E.G7 tumors. The growth of the same lymphoma was also effectively prevented by the antibody GK1.5, whose target molecule, CD4, was expressed on E.G7 cells in vivo. Furthermore, GK1.5 was able to eradicate established solid E.G7 tumors. GK1.5-mediated tumor elimination was due to its antitumor activity, and not to the elimination of regulatory CD4+ cells, based on unimpaired tumor growth in the absence of GK1.5 in animals that genetically lack CD4 T cells. In vitro, GK1.5 did not kill tumor cells: complement activation or apoptosis induction were not evident. In vivo, GK1.5-mediated tumor regression did not depend on natural killer cells, but it absolutely required CD8+ cells and intact Fcγ receptor. We conclude that, in the E.G7 model, the collaboration of antibody and CTL immunity was crucial for the successful immunotherapy of established tumors. The mechanism of this collaboration is discussed.
Keywords: controlled study; cancer growth; nonhuman; cd8 antigen; t lymphocyte; animal cell; mouse; animals; mice; apoptosis; gene expression; animal experiment; animal model; antineoplastic activity; tumor regression; tumor cells, cultured; mice, inbred c57bl; cancer inhibition; immunotherapy; cytotoxic t lymphocyte; t-lymphocytes, cytotoxic; lymphoma; natural killer cell; killer cells, natural; fc receptor; effector cell; cytotoxicity, immunologic; graft rejection; cd4 antigen; neoplasm transplantation; antigens, cd4; antibodies, neoplasm; antibody; cell killing; complement; antigens, cd8; cancer transplantation; cytotoxic lymphocyte; antigen antibody reaction; ovalbumin; complement activation; antibody-dependent cell cytotoxicity; male; female; priority journal; article
Journal Title: European Journal of Immunology
Volume: 27
Issue: 2
ISSN: 0014-2980
Publisher: Wiley V C H Verlag Gmbh  
Date Published: 1997-02-01
Start Page: 374
End Page: 382
Language: English
DOI: 10.1002/eji.1830270206
PUBMED: 9045907
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ljiljana V Vasovic
    12 Vasovic
  2. Rubendra Dyall
    33 Dyall
  3. Raphael A Clynes
    6 Clynes
  4. Jeffrey V. Ravetch
    72 Ravetch